相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies
Augusto C. Montezano et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure
Mustafa Karabacak et al.
ANGIOLOGY (2014)
Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: A multicenter, randomized, double-blind study
Josep Redon et al.
BLOOD PRESSURE (2014)
Nebivolol: Vasodilator Properties and Evidence for Relevance in Treatment of Cardiovascular Disease
Jonathan G. Howlett
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Nebivolol, But Not Metoprolol, Lowers Blood Pressure in Nitric Oxide-Sensitive Human Hypertension
Luis E. Okamoto et al.
HYPERTENSION (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
Michael A. Weber et al.
JOURNAL OF CLINICAL HYPERTENSION (2014)
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study
Thomas D. Giles et al.
LANCET (2014)
Economic impact of switching from metoprolol to nebivolol for hypertension treatment: a retrospective database analysis
Stephanie Chen et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial
Robert J. Weiss et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
CIRCULATION (2013)
Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?
Georgios Bouras et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: The CARNEBI trial
Mauro Contini et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Nebivolol Monotherapy in Younger Adults (Younger Than 55Years) With Hypertension: A Randomized, Placebo-Controlled Trial
Thomas D. Giles et al.
JOURNAL OF CLINICAL HYPERTENSION (2013)
Effects of Nebivolol on Aortic Compliance in Patients With Diabetes and Maximal Renin Angiotensin System Blockade: The EFFORT Study
Alexandros Briasoulis et al.
JOURNAL OF CLINICAL HYPERTENSION (2013)
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Saurav Chatterjee et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension The National Health and Nutrition Examination Survey, 2001 to 2010
Qiuping Gu et al.
CIRCULATION (2012)
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS
Bart A. Mulder et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study
Viviane M. Conraads et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
ß-Blockade: Benefits Beyond Blood Pressure Reduction?
John R. Cockcroft et al.
JOURNAL OF CLINICAL HYPERTENSION (2012)
Blood Pressure Effects of Combined β-Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Compared With the Individual Agents: A Placebo-Controlled Study With Nebivolol and Lisinopril
Michael A. Weber et al.
JOURNAL OF CLINICAL HYPERTENSION (2012)
Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension
Martin Serg et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2012)
Efficacy and Tolerability of Nebivolol in Stage I-II Hypertension: A Pooled Analysis of Data From Three Randomized, Placebo-Controlled Monotherapy Trials
Robert J. Weiss et al.
CLINICAL THERAPEUTICS (2011)
Differential Effects of Nebivolol and Metoprolol on Central Aortic Pressure and Left Ventricular Wall Thickness
Priit Kampus et al.
HYPERTENSION (2011)
Comparative Long Term Effects of Nebivolol and Carvedilol in Hypertensive Heart Failure Patients
Giuseppe Marazzi et al.
JOURNAL OF CARDIAC FAILURE (2011)
Reversal of subclinical left ventricular dysfunction by antihypertensive treatment: a prospective trial of nebivolol against metoprolol
Dragos Vinereanu et al.
JOURNAL OF HYPERTENSION (2011)
The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension
Ramprasad Kandavar et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Erectile Dysfunction in High-Risk Hypertensive Patients Treated with Beta-Blockade Agents
Alberto Cordero et al.
CARDIOVASCULAR THERAPEUTICS (2010)
Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD study
Otto Kamp et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Effects of beta-blockers on glucose and lipid metabolism
Vivian A. Fonseca
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension
J. M. Neutel et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension
Alberto Cordero et al.
POSTGRADUATE MEDICINE (2010)
Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension
Vasilios Papademetriou
AMERICAN JOURNAL OF CARDIOLOGY (2009)
What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?
Michala E. Pedersen et al.
CURRENT OPINION IN CARDIOLOGY (2009)
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
Alain Cohen-Solal et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Role of Pulse Pressure Amplification in Arterial Hypertension Experts' Opinion and Review of the Data
Alberto P. Avolio et al.
HYPERTENSION (2009)
Evolving Mechanisms of Action of Beta Blockers: Focus on Nebivolol
R. Preston Mason et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Nebivolol in Obese and Non-Obese Hypertensive Patients
Camila Manrique et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)
Dirk J. van Veldhuisen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Nebivolol The Somewhat-Different β-Adrenergic Receptor Blocker
Thomas Muenzel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
β-Blocker Use for the Stages of Heart Failure
Marc Klapholz
MAYO CLINIC PROCEEDINGS (2009)
Nebivolol Treatment Reduces Serum Levels of Asymmetric Dimethylarginine and Improves Endothelial Dysfunction in Essential Hypertensive Patients
Anna Fratta Pasini et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
β-Bolockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection
Azra Mahmud et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
A comparison of atenolol and nebivolol in isolated systolic hypertension
Zahid Dhakam et al.
JOURNAL OF HYPERTENSION (2008)
The vasoldilatory beta-blockers
Michala E. Pedersen et al.
CURRENT HYPERTENSION REPORTS (2007)
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: Data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial
Daniela Dobre et al.
AMERICAN HEART JOURNAL (2007)
Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)
Gregg C. Fonarow et al.
AMERICAN HEART JOURNAL (2007)
Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): Benefit of nebivolol versus metoprolol in hypertensive men
K. Brixius et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: The Yestono study
Andre C. Schmidt et al.
CLINICAL DRUG INVESTIGATION (2007)
Beneficial effects of switching from β-blockers to nebivolol on the erectile function of hypertensive patients
M Doumas et al.
ASIAN JOURNAL OF ANDROLOGY (2006)
Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis
LH Lindholm et al.
LANCET (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Quality of life and anti hypertensive effect with nebivolol and losartan
LM Van Bortel et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease
JP Lekakis et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study
I Edes et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Characterization of β1-adrenergic receptor selectivity of nebivolol and various other beta-blockers in human myocardium
MR Bristow et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men
B Boydak et al.
CLINICAL DRUG INVESTIGATION (2005)
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial
G Grassi et al.
BLOOD PRESSURE (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
β-Blocker treatment of patients with diastolic heart failure and arterial hypertension.: A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol
S Nodari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension
O Kamp et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Effect of nebivolol on left ventricular function in patients with chronic heart failure:: a pilot study
BR Brehm et al.
EUROPEAN JOURNAL OF HEART FAILURE (2002)
Augmentation index is associated with cardiovascular risk
J Nürnberger et al.
JOURNAL OF HYPERTENSION (2002)
Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress
E Arosio et al.
JOURNAL OF HYPERTENSION (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Central pulse pressure and mortality in end-stage renal disease
ME Safar et al.
HYPERTENSION (2002)
Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly
A Mazza et al.
BLOOD PRESSURE (2002)
Nebivolol reverses endothelial dysfunction in essential hypertension - A randomized, double-blind, crossover study
N Tzemos et al.
CIRCULATION (2001)
分享论文
